quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:32:45·535d
SECFiling
Kiromic BioPharma Inc. logo

Kiromic BioPharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

KRBP· Kiromic BioPharma Inc.
Health Care
Original source

Companies

  • KRBP
    Kiromic BioPharma Inc.
    Health Care

Related

  • SEC398d
    Kiromic BioPharma Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
  • SEC402d
    Kiromic BioPharma Inc. filed SEC Form 8-K: Other Events
  • SEC428d
    Amendment: SEC Form S-1/A filed by Kiromic BioPharma Inc.
  • PR429d
    Kiromic BioPharma Reports Patient 4 in Deltacel-01 Clinical Trial Reaches 10-Month Progression-Free Survival
  • SEC433d
    SEC Form 10-K filed by Kiromic BioPharma Inc.
  • SEC444d
    Amendment: Kiromic BioPharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
  • SEC444d
    Kiromic BioPharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
  • PR457d
    Kiromic BioPharma Reports Tumor Volume Decrease in Two Patients Enrolled in Deltacel-01
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022